|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-5-5
|
|
pubmed:abstractText |
Cyclooxygenase-2 (COX-2) is a well-known enzyme that promotes tumor growth and metastasis. Cyclooxygenase-2 is upregulated in a number of human epithelial tumors, but data about the significance of COX-2 in mesenchymal tumors are lacking. The purpose of this study was to determine COX-2 expression in uterine sarcomas and whether a relationship exists between COX-2 expression and clinicopathologic outcomes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1525-1438
|
|
pubmed:author |
pubmed-author:ChoiJong-SunJS,
pubmed-author:ChungHyun HoonHH,
pubmed-author:JeonYong-TarkYT,
pubmed-author:KangSokbomS,
pubmed-author:KangSoon-BeomSB,
pubmed-author:KimJae WeonJW,
pubmed-author:LeeChae HyeongCH,
pubmed-author:ParkIn-AeIA,
pubmed-author:ParkNoh-HyunNH,
pubmed-author:RohJu-WonJW,
pubmed-author:SongYong-SangYS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
668-72
|
|
pubmed:meshHeading |
pubmed-meshheading:21412163-Adult,
pubmed-meshheading:21412163-Aged,
pubmed-meshheading:21412163-Aged, 80 and over,
pubmed-meshheading:21412163-Cyclooxygenase 2,
pubmed-meshheading:21412163-Female,
pubmed-meshheading:21412163-Follow-Up Studies,
pubmed-meshheading:21412163-Humans,
pubmed-meshheading:21412163-Immunohistochemistry,
pubmed-meshheading:21412163-Leiomyosarcoma,
pubmed-meshheading:21412163-Middle Aged,
pubmed-meshheading:21412163-Prognosis,
pubmed-meshheading:21412163-Survival Analysis,
pubmed-meshheading:21412163-Tumor Markers, Biological,
pubmed-meshheading:21412163-Uterine Neoplasms
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Cyclooxygenase-2 is an independent predictor of poor prognosis in uterine leiomyosarcomas.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Dongguk University, Seoul, Republic of Korea.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
